BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38431305)

  • 21. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015.
    Genus TSE; Bouvier C; Wong KF; Srirajaskanthan R; Rous BA; Talbot DC; Valle JW; Khan M; Pearce N; Elshafie M; Reed NS; Morgan E; Deas A; White C; Huws D; Ramage J
    Br J Cancer; 2019 Nov; 121(11):966-972. PubMed ID: 31649320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomograms predict survival outcomes for distant metastatic pancreatic neuroendocrine tumor: A population based STROBE compliant study.
    Li G; Tian ML; Bing YT; Wang HY; Yuan CH; Xiu DR
    Medicine (Baltimore); 2020 Mar; 99(13):e19593. PubMed ID: 32221079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Retrospective Cohort Study of Histology-Proven Neuroendocrine Neoplasms in the Italian Area of Udine.
    Valent F; Tullio A; Kara E; Cipri C; Sciannimanico SM; Vescini F; Grimaldi F
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):448-457. PubMed ID: 32660412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model for predicting the overall survival of gastroenteropancreatic neuroendocrine neoplasms after surgery.
    Feng LH; Su T; Lu Y; Ren S; Huang L; Qin X; Liao T
    Scand J Gastroenterol; 2022 May; 57(5):581-588. PubMed ID: 35001789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
    Panzuto F; Merola E; Pavel ME; Rinke A; Kump P; Partelli S; Rinzivillo M; Rodriguez-Laval V; Pape UF; Lipp R; Gress T; Wiedenmann B; Falconi M; Delle Fave G
    Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomogram for individually predicting overall survival in rectal neuroendocrine tumours.
    Feng X; Wei G; Wang W; Zhang Y; Zeng Y; Chen M; Chen Y; Chen J; Zhou Z; Li Y
    BMC Cancer; 2020 Sep; 20(1):865. PubMed ID: 32907602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel nomogram combining depth of invasion and size can accurately predict the risk for regional nodal metastases for appendiceal neuroendocrine tumors (A-NET).
    Mosquera C; Fitzgerald TL; Vora H; Grzybowski M
    J Surg Oncol; 2017 Nov; 116(6):651-657. PubMed ID: 28608390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
    Martin JA; Warner RR; Wisnivesky JP; Kim MK
    Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
    Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
    Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality.
    Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L
    BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a nomogram prognostic model for patients with neuroendocrine tumors of the thymus.
    Tang JY; Gao HJ; Shi GD; Guo XK; Yu WQ; Wang HF; Wei YC
    Thorac Cancer; 2020 Sep; 11(9):2457-2464. PubMed ID: 32656987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study.
    Song Z; Zou L
    Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence, survival, and prognostic factors for patients with gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms: a SEER population-based study.
    Xu B; Zhang F; Wu R; Peng Y; Mao Z; Tong S
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15657-15669. PubMed ID: 37656242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
    Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
    Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
    Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
    Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
    Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine Tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
    Heng X; Chen B; Zhao K; Li J; Wu W; Peng Y; Zhong R
    PLoS One; 2023; 18(4):e0284930. PubMed ID: 37093837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.